Lannett Company recalled 8,544 bottles of Lisdexamfetamine Dimesylate Capsules on August 11, 2025. The recall occurred due to a labeling mix-up where 40 mg capsules were mislabeled as 30 mg. This issue poses a high risk to consumers who may receive incorrect dosages.
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
Consumers and healthcare providers should stop using this product immediately. Contact Lannett Company Inc. or your healthcare provider for guidance. Notification method: Letter
The recall involves Lisdexamfetamine Dimesylate Capsules, 40 mg, packaged in 100-count bottles. The affected lot number is 25280726A, with an expiration date of March 2027. These products were distributed nationwide.
The labeling error could lead to patients receiving an incorrect dosage of the medication. This poses a significant risk, especially in individuals relying on specific dosages for ADHD treatment.
Currently, no injuries or incidents have been reported as a direct result of this labeling error. However, the potential for serious health consequences exists if patients consume the incorrect dosage.
Consumers should immediately stop using the recalled product. Contact Lannett Company for guidance and further instructions regarding returns and refunds.
For more information, call Lannett Company at 1-800-XXX-XXXX or visit their website. Additional details are available on the FDA recall page.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.